Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CA602 antigen

Known as: CA602 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2005
Review
2005
 
Is this relevant?
Review
1999
Review
1999
 
Is this relevant?
1998
1998
In this study clinical studies were conducted on galactosyltransferase associated with tumour (GAT) as a newly developed marker… Expand
Is this relevant?
1994
1994
Serum samples from patients with benign or malignant diseases were measured for the newly developed tumor markers CA54/61 and… Expand
Is this relevant?
1993
1993
Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of… Expand
Is this relevant?
1991
1991
A cell line designated RMG‐II was established from the ascites of a patient with ovarian clear cell carcinoma. The chromosomal… Expand
Is this relevant?
1990
1990
We investigated the usefulness of CA602, a newly developed serum tumor marker, for ovarian cancer. When the cut-off value was set… Expand
Is this relevant?